Quarterly report pursuant to Section 13 or 15(d)

REVENUE (Details Narrative)

v3.24.1.1.u2
REVENUE (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Jan. 01, 2023
Revenue $ 25,962 $ 30,001    
Revenue, Remaining Performance Obligation, Amount 5,200      
Amortization of Deferred Sales Commissions 90 167    
Accumulated deficit (74,722)   $ (74,481)  
Trade Accounts Receivable [Member] | Accounting Standards Update 2016-13 [Member]        
Accumulated deficit       $ 186
Other Noncurrent Assets [Member]        
Deferred commissions 488 580    
Chronic Care Management [Member]        
Revenue 440 135    
Remote Patient Monitoring [Member]        
Revenue 140 11    
Professional Services [Member] | Unbilled Revenues [Member]        
Revenue 47 $ 100    
Group Purchasing Services [Member]        
Contract with Customer, Asset, after Allowance for Credit Loss $ 264